Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.74 |
| ▸ | CA2 | P00918 | 4/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.67 |
| ▸ | CA9 | Q16790 | 2/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | CA12 | O43570 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11588746 | 1.00 | ALDH1A1 (0.74) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL12633723 | 1.00 | ALDH1A1 (0.74) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL20186922 | 1.00 | ALDH1A1 (0.74) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL11557679 | 1.00 | ALDH1A1 (0.74) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL28162394 | 0.91 | ALDH1A1 (0.65) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL14129141 | 0.91 | ALDH1A1 (0.65) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL13351563 | 0.89 | ALDH1A1 (0.62) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL18688365 | 0.89 | ALDH1A1 (0.62) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL11458614 | 0.89 | S100B (0.66) | ALDH1A1CA2PTGS2CA9PTGS1 | |
| SCHEMBL22366969 | 0.89 | ALDH1A1 (0.62) | ALDH1A1CA2PTGS2CA9PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3707132-B1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | UNIV PARIS SACLAY (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-20220325053-A1 | METHOD FOR THE SYNTHESIS OF A TWO-DIMENSIONAL OR QUASI-TWO-DIMENSIONAL POLYMER FILM, THE TWO-DIMENSIONAL OR QUASI-TWO-DIMENSIONAL POLYMER FILM AND THE USE | Technische Universität Dresden (DE) | 2022-10-13 | — | — | US | disclosed |
| US-11034646-B2 | Method for the synthesis of unsymmetrical tertiary amines | Universite Paris-Saclay (FR) | 2021-06-15 | — | — | US | disclosed |
| WO-2021028429-A1 | METHOD FOR THE SYNTHESIS OF A TWO-DIMENSIONAL OR QUASI-TWO-DIMENSIONAL POLYMER FILM, THE TWO-DIMENSIONAL OR QUASI-TWO-DIMENSIONAL POLYMER FILM AND THE USE | Technische Universität Dresden (DE) | 2021-02-18 | — | — | WO | disclosed |
| US-20200255369-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | Universite Paris-Saclay (FR) | 2020-08-13 | — | — | US | disclosed |
| US-10335765-B2 | Complex of carbon structure and covalent organic framework, preparation method therefor, and use thereof | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2019-07-02 | — | — | US | disclosed |
| EP-2131233-B1 | LIQUID CRYSTAL DISPLAY DEVICE AND POLYMER FOR ALIGNING FILM MATERIAL | SHARP KK (JP) | 2017-03-29 | — | — | EP | disclosed |
| US-8623855-B2 | Azetidinone compounds and medical use thereof | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2014-01-07 | — | — | US | disclosed |
| US-20130170016-A1 | PHOTOREFRACTIVE DEVICE CONTAINING A CHROMOPHORE-DOPED POLYMER LAYER AND ITS MANUFACTURING METHOD | NITTO DENKO CORPORATION (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20130163086-A1 | SYSTEMS AND METHODS FOR IMPROVING THE PERFORMANCE OF A PHOTOREFRACTIVE DEVICE BY UTILIZING ELECTROLYTES | NITTO DENKO CORPORATION (JP) | 2013-06-27 | — | — | US | disclosed |
| US-7960435-B2 | Anti-cancer agents and androgen inhibition activity compound | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2011-06-14 | — | — | US | disclosed |
| US-20100113600-A1 | ANTI-CANCER AGENTS AND ANDROGEN INHIBITION ACTIVITY COMPOUND | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100102299-A1 | ORGANIC SEMICONDUCTOR COMPOSITE, ORGANIC TRANSISTOR MATERIAL AND ORGANIC FIELD EFFECT TRANSISTOR | TORAY INDUSTRIES, INC. (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20100102299-A1 | ORGANIC SEMICONDUCTOR COMPOSITE, ORGANIC TRANSISTOR MATERIAL AND ORGANIC FIELD EFFECT TRANSISTOR | TORAY INDUSTRIES, INC. (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20100096603-A1 | OPTICAL DEVICES RESPONSIVE TO NEAR INFRARED LASER AND METHODS OF MODULATING LIGHT | NITTO DENKO CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| US-20100096603-A1 | OPTICAL DEVICES RESPONSIVE TO NEAR INFRARED LASER AND METHODS OF MODULATING LIGHT | NITTO DENKO CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2009-12-10 | — | — | US | disclosed |
| WO-2009099898-A1 | OPTICAL DEVICES RESPONSIVE TO BLUE LASER AND METHOD OF MODULATING LIGHT | NITTO DENKO CORPORATION (JP) | 2009-08-13 | — | — | WO | disclosed |
| US-20090197186-A1 | OPTICAL DEVICES RESPONSIVE TO BLUE LASER AND METHOD OF MODULATING LIGHT | NITTO DENKO CORPORATION (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090197186-A1 | OPTICAL DEVICES RESPONSIVE TO BLUE LASER AND METHOD OF MODULATING LIGHT | NITTO DENKO CORPORATION (JP) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255369-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | ADH1C, ADH1A, ADH5 | ALDH1A1 179/4885CA2 4835/4885PTGS2 3275/4885 |
| US-11034646-B2 | Method for the synthesis of unsymmetrical tertiary amines | ADH1C, PNMT, ADH1A | ALDH1A1 182/4885CA2 4822/4885PTGS2 3092/4885 |
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | BCHE, ACHE, LIPE | ALDH1A1 3124/4885CA2 714/4885PTGS2 3599/4885 |
| US-20100113600-A1 | ANTI-CANCER AGENTS AND ANDROGEN INHIBITION ACTIVITY COMPOUND | AR, HTR3D, NR5A1 | ALDH1A1 763/4885CA2 2614/4885PTGS2 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.